RGNT

Regentis Biomaterials Ltd. Ordinary Shares (RGNT)

Stock · AMEX · Health Care

$2as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Resistance level
$3
Industry
Biotechnology: Pharmaceutical Preparations

Regentis Biomaterials Ltd. Ordinary Shares Competitors

Chosen by industry and closest market cap.

  • RGNT
    Regentis Biomaterials Ltd. Ordinary Shares
    $2
    ▼ 2.91%
    Market cap $13.13MP/E
  • COCP
    Cocrystal Pharma Inc. Common Stock
    $1.11
    ▼ 2.63%
    Market cap $12.96MP/E
    $0.76$2.67
  • AKTX
    Akari Therapeutics plc ADS
    $11.03
    ▲ 22.42%
    Market cap $12.88MP/E Infinity
    $3.02$49.6
  • PHIO
    Phio Pharmaceuticals Corp. Common Stock
    $1.13
    ▲ 0.45%
    Market cap $11.97MP/E
    $0.8127$4.19
  • AEON
    AEON Biopharma Inc. Class A Common Stock
    $0.3095
    ▲ 5.27%
    Market cap $14.41MP/E
    $0.1772$1.45
  • PTN
    Palatin Technologies Inc. Common Stock
    $10.48
    ▼ 0.10%
    Market cap $14.64MP/E 85.09
    $5.61$31
  • KTTA
    Pasithea Therapeutics Corp. Common Stock
    $0.5975
    ▲ 7.66%
    Market cap $14.92MP/E
    $0.281$2.06

P/E shows — for peers not currently carrying a live signal of their own.

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.